Back

Characteristics, treatment, and outcomes of early vs. late enrolees of the STRONG-HF trial.

12 May 2024 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - epidemiology, prognosis, outcome 3 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Mattia Arrigo

EOC - Ente Ospedaliero Cantonale, Lugano (Switzerland)

6 More presentations in this session

Presentation thumbnail
Obesity and clinical outcomes in acute decompensated heart failure according to left and right ventricular systolic function
Doctor D. Cocianni (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Impacts of heat exposure after the rainy season on heart failure in the elderly: linear and nonlinear associations
Doctor R. Fujimoto (Tsuyama, JP)
Abstract Slides Video
Presentation thumbnail
In-hospital course of patients with heart failure with Improved ejection fraction in the DELIVER Trial
Doctor M. Pabon (Boston, US)
Abstract Slides Video
Presentation thumbnail
Weight loss during hospitalization for heart failure while receiving intravenous loop diuretic is associated with lower risk of rehospitalization regardless BMI: data from the SwedeHF registry
Mr M. Erhardsson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Precision in prognostication: a comprehensive comparison of risk scores in the setting of cardiogenic shock
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - epidemiology, prognosis, outcome 3

The Event

Event poster

Heart Failure 2024

12 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
STRONG-HF in elderly patients
thumbnail
Congress Presentation
Safety, tolerability, and efficacy of uptitration of guideline-directed medical therapy for acute heart failure stratified by baseline risk
thumbnail
Congress Presentation
The consistency of the treatment benefit of remote hemodynamic monitoring in chronic heart failure: a predefined subgroup analysis of the randomised clinical Trial MONITOR-HF.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources